Contact
Please use this form to send email to PR contact of this press release:
VIDAC PHARMA Upcoming Inclusion in Open Market of Düsseldorf Stock Exchange, Primary Market Segment, and Public Offering
TO:
Max Herzberg
Vidac pharma Holding Plc
+972 54-425-7381